{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:03:36Z","timestamp":1785675816878,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s43440-020-00099-x","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T17:02:43Z","timestamp":1586451763000},"page":"680-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ortho-vanillin nanoparticle-doped glucan microspheres\u00a0exacerbate the anti-arthritic effects of methotrexate in adjuvant-induced\u00a0arthritis\u00a0in rats"],"prefix":"10.1007","volume":"72","author":[{"given":"Shiva","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-5798","authenticated-orcid":false,"given":"Jaleh","family":"Varshosaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-2324","authenticated-orcid":false,"given":"Valiolah","family":"Hajhashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"key":"99_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"RC Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778\u201399.","journal-title":"Arthritis Rheum"},{"issue":"21","key":"99_CR2","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.172501499","volume":"99","author":"PR Rajagopalan","year":"2002","unstructured":"Rajagopalan PR, Zhang Z, McCourt L, Dwyer M, Benkovic SJ, Hammes GG. Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics. Proc Natl Acad Sci. 2002;99(21):13481\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"99_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"J Wessels","year":"2008","unstructured":"Wessels J, Huizinga T, Guchelaar H-J. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology. 2008;47(3):249\u201355.","journal-title":"Rheumatology"},{"issue":"10","key":"99_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1515\/cclm.1993.31.10.667","volume":"31","author":"M Brody","year":"1993","unstructured":"Brody M, B\u00f6hm I, Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1\u03b2 to the interleukin 1 receptor on target cells. Clin Chem Lab Med. 1993;31(10):667\u201374.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"99_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/art.21573","volume":"54","author":"MH Weisman","year":"2006","unstructured":"Weisman MH, Furst DE, Park GS, Kremer JM, Smith KM, Wallace DJ, et al. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Arthritis Rheum. 2006;54(2):607\u201312.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"99_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/07420528.2011.553017","volume":"28","author":"H To","year":"2011","unstructured":"To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, et al. Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int. 2011;28(3):267\u201374.","journal-title":"Chronobiol Int"},{"issue":"6","key":"99_CR7","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1172\/JCI116884","volume":"92","author":"BN Cronstein","year":"1993","unstructured":"Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993;92(6):2675.","journal-title":"J Clin Invest"},{"issue":"9","key":"99_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ptr.2143","volume":"21","author":"I Tekeoglu","year":"2007","unstructured":"Tekeoglu I, Dogan A, Ediz L, Budancamanak M, Demirel A. Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models. Phytother Res. 2007;21(9):895\u20137.","journal-title":"Phytother Res"},{"issue":"6","key":"99_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/jid.1962.160","volume":"39","author":"LL Barich","year":"1962","unstructured":"Barich LL, Schwarz J, Barich D. Oral methotrexate in mice: a co-carcinogenic as well as an anti-tumor agent to methylcholanthrene-induced cutaneous tumors. J Invest Dermatol. 1962;39(6):615\u201320.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"99_CR10","first-page":"407","volume":"28","author":"L Yang","year":"2015","unstructured":"Yang L, Zhang J, Wang G. The effect of sodium hyaluronate treating knee osteoarthritis on synovial fluid interleukin-1\u03b2 and clinical treatment mechanism. Pak J Pharm Sci. 2015;28(1):407\u201310.","journal-title":"Pak J Pharm Sci"},{"issue":"4","key":"99_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/ard.54.4.289","volume":"54","author":"A Baici","year":"1995","unstructured":"Baici A, Lang A, H\u00f6rler D, Kissling R, Merlin C. Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis. 1995;54(4):289\u201397.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"99_CR12","first-page":"736","volume":"19","author":"Z Feng","year":"2015","unstructured":"Feng Z, Lian K. Identification of genes and pathways associated with osteoarthritis by bioinformatics analyses. Eur Rev Med Pharmacol Sci. 2015;19(5):736\u201344.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"99_CR13","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204(12):2803\u201312.","journal-title":"J Exp Med"},{"key":"99_CR14","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.2741\/1712","volume":"10","author":"E Andreakos","year":"2005","unstructured":"Andreakos E, Sacre S, Foxwell BM, Feldmann M. The toll-like receptor-nuclear factor _B pathway in rheumatoid arthritis. Front Biosci. 2005;10:2478\u201388.","journal-title":"Front Biosci"},{"key":"99_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cellimm.2005.04.018","volume":"233","author":"F Brentano","year":"2005","unstructured":"Brentano F, Kyburz D, Schorr O, Gay R, Gay S. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol. 2005;233:90\u20136.","journal-title":"Cell Immunol"},{"key":"99_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.bor.0000127108.08398.34","volume":"16","author":"R Seibl","year":"2004","unstructured":"Seibl R, Kyburz D, Lauener RP, Gay S. Pattern recognition receptors and their involvement in the pathogenesis of arthritis. Curr Opin Rheumatol. 2004;16:411\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"99_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"M Feldmann","year":"2001","unstructured":"Feldmann M, Maini RN. Anti-TNF therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol. 2001;19:163\u201396.","journal-title":"Annu Rev Immunol"},{"key":"99_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intimm\/dxh186","volume":"17","author":"K Takeda","year":"2005","unstructured":"Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1\u201314.","journal-title":"Int Immunol"},{"key":"99_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0002-9440(10)63918-1","volume":"162","author":"R Seibl","year":"2003","unstructured":"Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003;162:1221\u20137.","journal-title":"Am J Pathol"},{"key":"99_CR20","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/art.21155","volume":"52","author":"L De Rycke","year":"2005","unstructured":"De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys EM, Baeten D. Tumor necrosis factor blockade treatment downmodulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum. 2005;52:2146\u201358.","journal-title":"Arthritis Rheum"},{"key":"99_CR21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/art.20219","volume":"50","author":"M Iwahashi","year":"2004","unstructured":"Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, et al. Expression of Toll-like receptor 2 on CD16_ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004;50:1457\u201367.","journal-title":"Arthritis Rheum"},{"key":"99_CR22","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1002\/art.20678","volume":"50","author":"TR Radstake","year":"2004","unstructured":"Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, Barrera P, et al. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon. Arthritis Rheum. 2004;50:3856\u201365.","journal-title":"Arthritis Rheum"},{"issue":"17","key":"99_CR23","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1073\/pnas.1422576112","volume":"112","author":"P Mistry","year":"2015","unstructured":"Mistry P, Laird MH, Schwarz RS, Greene S, Dyson T, Snyder GA, et al. Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain. Proc Natl Acad Sci USA. 2015;112(17):5455\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"99_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/bc700329p","volume":"19","author":"ER Soto","year":"2008","unstructured":"Soto ER, Ostroff GR. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug Chem. 2008;19(4):840\u20138.","journal-title":"Bioconjug Chem"},{"issue":"2","key":"99_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4049\/jimmunol.173.2.797","volume":"173","author":"F Hong","year":"2004","unstructured":"Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, et al. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004;173(2):797\u2013806.","journal-title":"J Immunol"},{"issue":"5","key":"99_CR26","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1128\/IAI.00086-09","volume":"77","author":"H Huang","year":"2009","unstructured":"Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and Toll-like receptor agonists. Infect Immun. 2009;77(5):1774\u2013811.","journal-title":"Infect Immun"},{"issue":"12","key":"99_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.molimm.2003.10.007","volume":"40","author":"J Herre","year":"2004","unstructured":"Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol. 2004;40(12):869\u201376.","journal-title":"Mol Immunol"},{"issue":"38","key":"99_CR28","doi-asserted-by":"publisher","first-page":"10635","DOI":"10.1039\/c1cc14019a","volume":"47","author":"S Figueiredo","year":"2011","unstructured":"Figueiredo S, Moreira J, Geraldes CG, Rizzitelli S, Aimeb S, Terreno E. Yeast cell wall particles: a promising class of nature-inspired microcarriers for multimodal imaging. Chem Commun. 2011;47(38):10635\u20137.","journal-title":"Chem Commun"},{"issue":"4","key":"99_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/polym2040681","volume":"2","author":"ER Soto","year":"2010","unstructured":"Soto ER, Kim YS, Lee J, Kornfeld H, Ostroff GR. Glucan particle encapsulated rifampicin for targeted delivery to macrophages. Polymers. 2010;2(4):681\u20139.","journal-title":"Polymers"},{"issue":"1","key":"99_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4049\/jimmunol.1200603","volume":"189","author":"H Huang","year":"2012","unstructured":"Huang H, Ostroff GR, Lee CK, Agarwal S, Ram S, Rice PA, et al. Relative contributions of dectin-1 and complement to immune responses to particulate \u03b2-glucans. J Immunol. 2012;189(1):312\u20137.","journal-title":"J Immunol"},{"issue":"3","key":"99_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jconrel.2013.09.007","volume":"172","author":"RD Smet","year":"2013","unstructured":"Smet RD, Demoor T, Verschuere S, Dullaers M, Ostroff GR, Leclercq G, et al. \u03b2-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination. J Control Release. 2013;172(3):671\u20138.","journal-title":"J Control Release"},{"key":"99_CR32","first-page":"1743","volume":"10","author":"M Yu","year":"2015","unstructured":"Yu M, Chen Z, Guo W, Wang J, Feng Y, Kong X, et al. Specifically targeted delivery of protein to phagocytic macrophages. Int J Nanomedicine. 2015;10:1743\u201357.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"99_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5173(97)00149-X","volume":"155","author":"E Leo","year":"1997","unstructured":"Leo E, Vandelli MA, Cameroni R, Forni F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int J Pharm. 1997;155(1):75\u201382.","journal-title":"Int J Pharm"},{"key":"99_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/02652048509033841","volume":"2","author":"N Willmott","year":"1985","unstructured":"Willmott N, Cummings J, Florence AT. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres. J Microencapsul. 1985;2:293\u2013304.","journal-title":"J Microencapsul"},{"issue":"1","key":"99_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1556-276X-9-343","volume":"9","author":"Z Yu","year":"2014","unstructured":"Yu Z, Yu M, Zhang Z, Hong G, Xiong Q. Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear. Nanoscale Res Lett. 2014;9(1):343.","journal-title":"Nanoscale Res Lett"},{"key":"99_CR36","first-page":"669","volume":"5","author":"D Zhao","year":"2010","unstructured":"Zhao D, Zhao X, Zu Y, Li J, Zhang Y, Jiang R, et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine. 2010;5:669\u201377.","journal-title":"Int J Nanomedicine"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43440-020-00099-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:44:27Z","timestamp":1617925467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43440-020-00099-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00099-x","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"14 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}